KNTK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions FTAIM Q1 2026 Earnings Preferred Shares Steady as EPS Falls Short of Estimates UFCS Q1 2026 Earnings Strong EPS Beat Reflects Improved Underwriting Performance Remitly Q1 2026 Earnings EPS Surges Past Estimates with 918 Beat Telomir Pharmaceuticals Q4 2025 Earnings Wider Than Expected Loss Highlights ClinicalStage Challenges HUN Q1 2026 Earnings NarrowerthanExpected Loss Amidst Challenging Chemical Markets